Mark Pruzanski, President & CEO at INTERCEPT PHARMACEUTICALS, INC. (ICPT), sold 22,394 shares at $100.38 ($2.3M) on 2018-11-15, disclosed to the SEC on 2018-11-16.
Open-market sale of $2.3M ICPT by President & CEO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $100.38 | 18,873 | $1.9M | 84.2% |
| 2 | $101.13 | 3,521 | $356K | 15.8% |
| Total | $100.50 avg | 22,394 | $2.3M | 100% |
| Filing → |
| ICPT | SELL | 2019-11-27 | $5.0M | — | Filing → |
| ICPT | SELL | 2018-11-16 | $9.1M | — | Filing → |
| ICPT | SELL | 2018-11-16 | $356K | — | Filing → |